Blog
RSS FeedPosted by Michael Wonder on 01 Sep 2022
PBS listing for ovarian cancer and kidney disease
1 September 2022 - From 1 September 2022, Australians will have access to new and expanded medicines on the Pharmaceutical Benefits ...
Posted by Michael Wonder on 31 Aug 2022
Kidney disease drug dapagliflozin added to Pharmaceutical Benefits Scheme
31 August 2022 - Lachlan Ross describes his more than a decade-long battle with kidney failure as "very long, and very ...
Posted by Michael Wonder on 31 Aug 2022
Schedule of Pharmaceutical Benefits - 1 September 2022
1 September 2022 - The September 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Aug 2022
Spinal muscular atrophy community rejoices as 'life-changing' drug Spinraza approved for adults
30 August 2022 - "I have hope again," says Juanita Vernon as the 52 year old tearfully discusses her feelings about ...
Posted by Michael Wonder on 30 Aug 2022
First new kidney treatment in 20 years delays dialysis and transplant
31 August 2022 - Kidney disease is Australia’s silent killer, with nine in 10 patients unaware they have it until too ...
Posted by Michael Wonder on 28 Aug 2022
Ovarian cancer drug that costs up to $130k will soon be affordable for hundreds of patients
28 August 2022 - A drug that works to prolong survival for some patients with advanced ovarian cancer is being ...
Posted by Michael Wonder on 19 Aug 2022
1 September 2022 updates as part of the digital transformation of authority required (written) PBS listings
19 August 2022 - From 1 September 2022, the PBS listings for certain cancer medicines will be updated as part of ...
Posted by Michael Wonder on 03 Aug 2022
Supply a factor in restricting COVID vaccines for babies and toddlers
3 August 2022 - Most parents of babies and toddlers will not be able to access a COVID vaccine approved ...
Posted by Michael Wonder on 03 Aug 2022
COVID-19 vaccination for children aged 6 months to under 5 years
3 August 2022 - The Albanese Government has accepted a recommendation from the Australian Technical Advisory Group on Immunisation to make ...
Posted by Michael Wonder on 01 Aug 2022
Listing breakthrough brings hope for people with spinal condition
1 August 2022 - Adults with debilitating spinal muscular atrophy will for the first time have access to a subsidised ...
Posted by Michael Wonder on 01 Aug 2022
PBS listings will help people with spinal muscular atrophy, schizophrenia and multiple sclerosis
1 August 2022 - From today, Australians will have access to new and updated PBS listings, including a new spinal ...
Posted by Michael Wonder on 31 Jul 2022
Schedule of Pharmaceutical Benefits - 1 August 2022
1 August 2022 - The August 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 10 Jul 2022
Millions of Australians to gain access to COVID treatments
10 July 2022 - Eligibility for potentially lifesaving COVID-19 antiviral treatments will be widened from tomorrow, Monday 11 July. ...
Posted by Michael Wonder on 10 Jul 2022
COVID-19 oral treatment eligibility expanded from 11 July 2022
10 July 2022 - From 11 July 2022, more Australians at higher risk of developing severe COVID-19 will be able to ...
Posted by Michael Wonder on 08 Jul 2022
Doctors, pharmacists call for better support to prescribe anti-virals
8 July 2022 - Pandemic measures including home delivery of medicines and subsidised Telehealth appointments should be reinstated to allow ...